FiberLocker® System Augmentation of Rotator Cuff Repairs
1 other identifier
interventional
60
1 country
4
Brief Summary
The purpose of this study is to prospectively evaluate healing, functional clinical outcomes, and safety of arthroscopic rotator cuff repairs augmented with the FiberLocker® System (encompassing the SpeedPatch® PET and the FiberLocker® Instrument SN). The primary outcome measure is healing evaluation based on Magnetic Resonance Imaging (MRI) at a minimum of 6 months post-operatively. The secondary outcome measures are the Sugaya classification, Goutallier Stage and tendon quality based on MRI as well as objective scores and patient-reported outcome measures (PROMs) from validated outcome scoring systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2025
CompletedFirst Posted
Study publicly available on registry
April 9, 2025
CompletedStudy Start
First participant enrolled
August 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2028
December 1, 2025
November 1, 2025
1.2 years
March 6, 2025
November 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Healing Evaluation
The primary outcome measure is healing evaluation based on Magnetic Resonance Imaging (MRI) at a minimum of 6 months post-operatively. A standard shoulder MRI protocol utilizing a minimum of a 1.5 Tesla magnet will be utilized. The cuff integrity will be classified using the 5 categories described by Sugaya et al. Thereby, type IV and V are considered as retear and type I, II, and III as healed. The healing rate will be estimated and reported descriptively, and a 95% confidence interval will be reported assuming a binomial distribution (unless otherwise noted).
Pre-operatively & minimum 6 months post-operatively
Secondary Outcomes (11)
Sugaya Classification
Minimum 6 months post-operatively
Goutallier Stage
Pre-operatively & minimum 6 months post-operatively
Tendon Quality
Pre-operatively & minimum 6 months post-operatively
American Shoulder and Elbow Surgeons (ASES) Score
Pre-operatively, Post-operatively: 6 months, 12 months, 24 months
Single Assessment Numeric Evaluation (SANE) Score
Pre-operatively, Post-operatively: 6 months, 12 months, 24 months
- +6 more secondary outcomes
Study Arms (1)
Augmentation of Rotator Cuff Repair using the FiberLocker® System
EXPERIMENTALAll enrolled participants will undergo repair of the rotator cuff tear, with augmentation utilizing the FiberLocker® System.
Interventions
The FiberLocker® System is a mechanical augmentation system that includes an implant (SpeedPatch® PET) and an instrument (FiberLocker® Instrument SN) for its attachment. The implant is composed of non-woven PET fibers, and the instrument features a reciprocating needle at its tip, which pushes the individual patch fibers into the underlying tendon tissue.
Eligibility Criteria
You may qualify if:
- The Subject is between the ages of 30 and 70 years.
- Subject is planning to undergo arthroscopic surgery for full-thickness rotator cuff tear (RCT)
- Tear size ≥ 2 cm
- Primary rotator cuff repair
- Subject preoperative MRI obtained within 1 year prior to surgery
You may not qualify if:
- The Subject is unable or unwilling to sign the Patient Informed Consent, approved by the Institutional Review Board.
- The Subject objects to the use of the FiberLocker® System
- History or known allergy or intolerance to polyester
- Complete full-thickness subscapularis tears of \> than the superior 1/3 of the tendon (Lafosse grade 3 and above)
- Hamada grade III and above
- Less than 2 mm joint space of the glenohumeral joint on either an anteroposterior or axillary radiograph
- Recurrent shoulder instability
- Corticosteroid injection in the operative shoulder within three months before surgery
- Subjects with inflammatory or auto-immune based joint diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus)
- Subjects with current acute infection in the area surrounding the surgical site
- Revision rotator cuff repair
- Pregnant or planning to become pregnant during the study period
- Subject is breastfeeding during the study period
- Subject has conditions or circumstances that would interfere with study requirements
- Partial rotator cuff repairs
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Rush University Medical Center
Chicago, Illinois, 60612, United States
MedStar Health Research Institute
Columbia, Maryland, 21044, United States
Wake Forest University
Winston-Salem, North Carolina, 27157, United States
Southern Oregon Orthopedics Research Foundation
Medford, Oregon, 97504, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2025
First Posted
April 9, 2025
Study Start
August 5, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
April 1, 2028
Last Updated
December 1, 2025
Record last verified: 2025-11